Handelsbanken Fonder AB reduced its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 7.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 975,089 shares of the biopharmaceutical company's stock after selli